{"pmid":32376583,"pmcid":"PMC7167313","title":"[Diagnosis and treatment of an elderly patient with secondary cerebral infarction caused by COVID-19].","text":["[Diagnosis and treatment of an elderly patient with secondary cerebral infarction caused by COVID-19].","We review the experience with the diagnosis and treatment of secondary cerebral infarction in an elderly patient with coronavirus disease 2019 (COVID-19). COVID-19 has rapid disease progression with a high mortality rate in elderly patients, and physicians should be alert to secondary bacterial infection that may result in coagulation dysfunction and cerebral infarction. Early anti-infection therapy, immune regulation and appropriate anticoagulation intervention may help improve the prognosis of the patients.","Nan Fang Yi Ke Da Xue Xue Bao","He, Jin","Cheng, Gong","Xu, Wenwei","Zhang, Lengzhen","Zeng, Zhenhua","32376583"],"abstract":["We review the experience with the diagnosis and treatment of secondary cerebral infarction in an elderly patient with coronavirus disease 2019 (COVID-19). COVID-19 has rapid disease progression with a high mortality rate in elderly patients, and physicians should be alert to secondary bacterial infection that may result in coagulation dysfunction and cerebral infarction. Early anti-infection therapy, immune regulation and appropriate anticoagulation intervention may help improve the prognosis of the patients."],"journal":"Nan Fang Yi Ke Da Xue Xue Bao","authors":["He, Jin","Cheng, Gong","Xu, Wenwei","Zhang, Lengzhen","Zeng, Zhenhua"],"date":"2020-05-08T11:00:00Z","year":2020,"_id":"32376583","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.12122/j.issn.1673-4254.2020.03.10","keywords":["covid-19","cerebral infarction","elderly patients","secondary bacterial infection"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1666597097394143232,"score":9.490897,"similar":[{"pmid":32390931,"pmcid":"PMC7188982","title":"A Case of Coronavirus Disease 2019 With Concomitant Acute Cerebral Infarction and Deep Vein Thrombosis.","text":["A Case of Coronavirus Disease 2019 With Concomitant Acute Cerebral Infarction and Deep Vein Thrombosis.","We report a case of a 75-year-old woman diagnosed with severe coronavirus disease 2019 (COVID-19) complicated by acute cerebral infarction. The patient was admitted to our hospital on 5 February 2020 with severe COVID-19. On 20 February 2020, she was diagnosed with concomitant acute cerebral infarction via head computed tomography (CT) and deep vein thrombosis in both lower limbs. After symptomatic and supportive treatments, the patient was discharged on 13 March 2020. She will comply with quarantine for another 2 weeks and receive rehabilitation training from a specialist doctor. Cerebral infarction should be considered and promptly managed in patients with COVID-19.","Front Neurol","Zhou, Bo","She, Jianqing","Wang, Yadan","Ma, Xiancang","32390931"],"abstract":["We report a case of a 75-year-old woman diagnosed with severe coronavirus disease 2019 (COVID-19) complicated by acute cerebral infarction. The patient was admitted to our hospital on 5 February 2020 with severe COVID-19. On 20 February 2020, she was diagnosed with concomitant acute cerebral infarction via head computed tomography (CT) and deep vein thrombosis in both lower limbs. After symptomatic and supportive treatments, the patient was discharged on 13 March 2020. She will comply with quarantine for another 2 weeks and receive rehabilitation training from a specialist doctor. Cerebral infarction should be considered and promptly managed in patients with COVID-19."],"journal":"Front Neurol","authors":["Zhou, Bo","She, Jianqing","Wang, Yadan","Ma, Xiancang"],"date":"2020-05-12T11:00:00Z","year":2020,"_id":"32390931","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.3389/fneur.2020.00296","keywords":["covid-19","ct","acute cerebral infarction","case","thrombosis"],"topics":["Case Report"],"weight":1,"_version_":1666528580061888512,"score":183.04149},{"pmid":32307298,"pmcid":"PMC7162634","title":"Severe cerebral involvement in adult-onset hemophagocytic lymphohistiocytosis.","text":["Severe cerebral involvement in adult-onset hemophagocytic lymphohistiocytosis.","The diagnosis of hemophagocytic lymphohistiocytosis (HLH) with cerebral involvement is challenging given the rarity of HLH and its resemblance to the much more common severe sepsis. Timely diagnosis and treatment may be lifesaving. We report two cases demonstrating different and rare forms of severe brain involvement in adult patients with HLH: acute necrotizing encephalopathy, and diffuse hemorrhagic disease due to disseminated intravascular coagulation. Severe HLH with brain involvement in adults is rare. HLH with cerebral involvement should be considered in patients presenting with severe systemic inflammatory response syndrome (SIRS) but negative cultures and unusual or unexpectedly severe clinical and/or radiologic signs of cerebral dysfunction. Similar brain injury may occur in patients with cytokine storm syndrome due to COVID-19. BACKGROUND: Hemophagocytic lymphohistiocytosis (HLH) presents with fevers, rash, organomegaly, cytopenia, and increased triglycerides and ferritin (Ramos-Casals et al., 2014) [1]. Neurologic abnormalities are reported in about one-third of patients (Cai et al., 2017), including a few cases of acute necrotizing encephalopathy (ANE) (Xiujuan et al., 2015). Coagulation abnormalities are frequent in HLH patients (Valade et al., 2015). OBJECTIVE: To raise awareness about the importance of early diagnosis and treatment of HLH with neurological involvement to prevent serious complications and demise.","J Clin Neurosci","Radmanesh, Farid","Rodriguez-Pla, Alicia","Pincus, Michael D","Burns, Joseph D","32307298"],"abstract":["The diagnosis of hemophagocytic lymphohistiocytosis (HLH) with cerebral involvement is challenging given the rarity of HLH and its resemblance to the much more common severe sepsis. Timely diagnosis and treatment may be lifesaving. We report two cases demonstrating different and rare forms of severe brain involvement in adult patients with HLH: acute necrotizing encephalopathy, and diffuse hemorrhagic disease due to disseminated intravascular coagulation. Severe HLH with brain involvement in adults is rare. HLH with cerebral involvement should be considered in patients presenting with severe systemic inflammatory response syndrome (SIRS) but negative cultures and unusual or unexpectedly severe clinical and/or radiologic signs of cerebral dysfunction. Similar brain injury may occur in patients with cytokine storm syndrome due to COVID-19. BACKGROUND: Hemophagocytic lymphohistiocytosis (HLH) presents with fevers, rash, organomegaly, cytopenia, and increased triglycerides and ferritin (Ramos-Casals et al., 2014) [1]. Neurologic abnormalities are reported in about one-third of patients (Cai et al., 2017), including a few cases of acute necrotizing encephalopathy (ANE) (Xiujuan et al., 2015). Coagulation abnormalities are frequent in HLH patients (Valade et al., 2015). OBJECTIVE: To raise awareness about the importance of early diagnosis and treatment of HLH with neurological involvement to prevent serious complications and demise."],"journal":"J Clin Neurosci","authors":["Radmanesh, Farid","Rodriguez-Pla, Alicia","Pincus, Michael D","Burns, Joseph D"],"date":"2020-04-21T11:00:00Z","year":2020,"_id":"32307298","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.jocn.2020.04.054","keywords":["acute necrotizing encephalopathy","adult onset still's disease","diffuse hemorrhagic encephalopathy","disseminated intravascular coagulation","hemophagocytic syndrome"],"locations":["organomegaly","cytopenia"],"e_drugs":["Triglycerides"],"topics":["Case Report"],"weight":1,"_version_":1666138491286716416,"score":135.75055},{"pmid":32448041,"title":"Covid-19 induced superimposed bacterial infection.","text":["Covid-19 induced superimposed bacterial infection.","Viral respiratory infections are very common and they are frequently eliminated from the body without any detrimental consequences. Secondary serious bacterial infection has been an apprehension expressed by health care providers, and this fear has been exacerbated in the era of Covid-19. Several published studies have shown an association between Covid-19 illness and secondary bacterial infection. However, the proposed mechanism by which a virus can develop a secondary bacterial infection is not well delineated. The aim of this commentary is to update the current evidence of the risk of bacterial infection in patients with Covid-19. We present several clinical studies related to the topic as well as a brief review of the potential pathophysiology of secondary infections that could present with Covid-19.","J Biomol Struct Dyn","Hendaus, Mohamed A","Jomha, Fatima A","32448041"],"abstract":["Viral respiratory infections are very common and they are frequently eliminated from the body without any detrimental consequences. Secondary serious bacterial infection has been an apprehension expressed by health care providers, and this fear has been exacerbated in the era of Covid-19. Several published studies have shown an association between Covid-19 illness and secondary bacterial infection. However, the proposed mechanism by which a virus can develop a secondary bacterial infection is not well delineated. The aim of this commentary is to update the current evidence of the risk of bacterial infection in patients with Covid-19. We present several clinical studies related to the topic as well as a brief review of the potential pathophysiology of secondary infections that could present with Covid-19."],"journal":"J Biomol Struct Dyn","authors":["Hendaus, Mohamed A","Jomha, Fatima A"],"date":"2020-05-26T11:00:00Z","year":2020,"_id":"32448041","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1080/07391102.2020.1772110","keywords":["covid-19","pathogenesis","secondary bacterial infection","studies"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1667785213977034752,"score":122.64292},{"pmid":32228738,"pmcid":"PMC7156566","title":"Mortality Rate of Infection With COVID-19 in Korea From the Perspective of Underlying Disease.","text":["Mortality Rate of Infection With COVID-19 in Korea From the Perspective of Underlying Disease.","On December 31, 2019 the China National Health Commission (NHC) reported that an unknown cause of pneumonia had been detected in Wuhan in Hubei province. On February 12, the disease caused by the novel coronavirus (2019-nCoV) was given a formal name, COVID-19. On January 20, 2020, the first case of COVID-19 was confirmed in Korea. The age-specific death rate was the highest among patients over 70 years of age, with underlying diseases in their circulatory system, such as myocardial infarction, cerebral infraction, arrythmia, and hypertension. Patients with underlying disease who are 70 years of age or older should recognize that there is a high possibility of developing a serious disease in case of viral infection and follow strict precautions.","Disaster Med Public Health Prep","Kang, Yun-Jung","32228738"],"abstract":["On December 31, 2019 the China National Health Commission (NHC) reported that an unknown cause of pneumonia had been detected in Wuhan in Hubei province. On February 12, the disease caused by the novel coronavirus (2019-nCoV) was given a formal name, COVID-19. On January 20, 2020, the first case of COVID-19 was confirmed in Korea. The age-specific death rate was the highest among patients over 70 years of age, with underlying diseases in their circulatory system, such as myocardial infarction, cerebral infraction, arrythmia, and hypertension. Patients with underlying disease who are 70 years of age or older should recognize that there is a high possibility of developing a serious disease in case of viral infection and follow strict precautions."],"journal":"Disaster Med Public Health Prep","authors":["Kang, Yun-Jung"],"date":"2020-04-02T11:00:00Z","year":2020,"_id":"32228738","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.1017/dmp.2020.60","keywords":["covid-19","mortality rate","over 70","perspective","prevention","underlying diseases"],"locations":["Wuhan","Hubei","South Korea","South Korea"],"countries":["China","Korea, Republic of"],"countries_codes":["CHN|China","KOR|Korea, Republic of"],"topics":["Diagnosis","Prevention"],"weight":1,"_version_":1666138492170665986,"score":121.587746},{"pmid":32499448,"title":"Comparison of clinical characteristics and outcomes of patients with coronavirus disease 2019 at different ages.","text":["Comparison of clinical characteristics and outcomes of patients with coronavirus disease 2019 at different ages.","BACKGROUND: Information about the clinical characteristics and mortality of patients with coronavirus disease 2019 at different ages is limited. RESULTS: The older group had more patients with dyspnea and fewer patients with fever and muscle pain. Older patients had more underlying diseases, secondary infection, myocardial injury, renal dysfunction, coagulation dysfunction, and immune dysfunction on admission. More older patients received immunoglobulin therapy and mechanical ventilation. The proportions of patients with multiple organ injuries, critically ill patients and death increased significantly with age. The older groups had higher cumulative death risk than the younger group. Hypertension, cerebrovascular disease, comorbidities, acute cardiac injury, shock and complications are independent predictors of death. CONCLUSIONS: The symptoms of the elderly patients were more atypical, with more comorbidities, secondary infection, organ injuries, immune dysfunction and a higher risk of critical illness. Older age was an important risk factor for mortality. METHODS: 1000 patients diagnosed with coronavirus disease 2019 from January 1, 2020 to February 14, 2020 were enrolled. According to age, patients were divided into group 1 (<60 years old), group 2 (60-74 years old) and group 3 (>/=75 years old). The clinical symptoms, first laboratory results, CT findings, organ injuries, disease severity and mortality were analyzed.","Aging (Albany NY)","Zhao, Mengmeng","Wang, Menglong","Zhang, Jishou","Gu, Jian","Zhang, Pingan","Xu, Yao","Ye, Jing","Wang, Zhen","Ye, Di","Pan, Wei","Shen, Bo","He, Hua","Liu, Mingxiao","Liu, Menglin","Luo, Zhen","Li, Dan","Liu, Jianfang","Wan, Jun","32499448"],"abstract":["BACKGROUND: Information about the clinical characteristics and mortality of patients with coronavirus disease 2019 at different ages is limited. RESULTS: The older group had more patients with dyspnea and fewer patients with fever and muscle pain. Older patients had more underlying diseases, secondary infection, myocardial injury, renal dysfunction, coagulation dysfunction, and immune dysfunction on admission. More older patients received immunoglobulin therapy and mechanical ventilation. The proportions of patients with multiple organ injuries, critically ill patients and death increased significantly with age. The older groups had higher cumulative death risk than the younger group. Hypertension, cerebrovascular disease, comorbidities, acute cardiac injury, shock and complications are independent predictors of death. CONCLUSIONS: The symptoms of the elderly patients were more atypical, with more comorbidities, secondary infection, organ injuries, immune dysfunction and a higher risk of critical illness. Older age was an important risk factor for mortality. METHODS: 1000 patients diagnosed with coronavirus disease 2019 from January 1, 2020 to February 14, 2020 were enrolled. According to age, patients were divided into group 1 (<60 years old), group 2 (60-74 years old) and group 3 (>/=75 years old). The clinical symptoms, first laboratory results, CT findings, organ injuries, disease severity and mortality were analyzed."],"journal":"Aging (Albany NY)","authors":["Zhao, Mengmeng","Wang, Menglong","Zhang, Jishou","Gu, Jian","Zhang, Pingan","Xu, Yao","Ye, Jing","Wang, Zhen","Ye, Di","Pan, Wei","Shen, Bo","He, Hua","Liu, Mingxiao","Liu, Menglin","Luo, Zhen","Li, Dan","Liu, Jianfang","Wan, Jun"],"date":"2020-06-06T11:00:00Z","year":2020,"_id":"32499448","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.18632/aging.103298","keywords":["2019 novel coronavirus","covid-19","age","clinical characteristics","coronavirus disease 2019","prognosis"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1668804508935782400,"score":120.31227}]}